ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MBOT vs LNSR // PIOTROSKI F-SCORE QUALITY

Microbot Medical Inc. (NASDAQ) VS. LENSAR Inc. (NASDAQ) • 15-METRIC TALLY: MBOT 4 — LNSR 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: LNSR
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBOT VS. LNSR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MBOT LNSR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 39.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -15.80% -35.00% +19.20 MBOT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.42% -20.33% +2.91 MBOT /fcf-yield <GO>
Operating Margin — -47.60% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 12.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 4/9 -2.00 LNSR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.5 34.6 +13.97 MBOT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $75.2M $73.3M $1.9M MBOT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MBOT REV LNSR REV MBOT GROSS % LNSR GROSS % MBOT FCF LNSR FCF
FY 2025 $0 $51.7M — 39.4% -$13.1M -$14.9M
FY 2024 $0 $46.0M — 39.9% -$8.9M -$2.4M
FY 2023 $0 $35.7M — — -$8.5M -$9.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBOT // BETA —
LNSR // BETA —